Gyre Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Han Ying
Chief executive officer
US$21.1k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Han Ying (57 yo)
less than a year
Tenure
US$21,078
Compensation
Dr. Han Ying, Ph D., serves as a Director of Gyre Therapeutics, Inc. since October 30, 2023 and serves as its Chief Executive Officer from January 15, 2024. Dr. Han Ying boasts more than two decades of exp...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$21.08k | no data | |
| President & Director | less than a year | no data | 3.44% $ 46.4m | |
| Chief Financial Officer | less than a year | US$308.68k | no data | |
| Chief Operating Officer | less than a year | US$274.62k | 0% $ 0 | |
| Senior Vice President of Finance | no data | no data | 0% $ 0 |
0.6yrs
Average Tenure
53yo
Average Age
Experienced Management: GYRE's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$21.08k | no data | |
| President & Director | less than a year | no data | 3.44% $ 46.4m | |
| Independent Director | less than a year | US$1.88m | 0.0027% $ 35.9k | |
| Director | 1.4yrs | US$1.88m | 0% $ 0 | |
| Chairman of the Board | 1.4yrs | US$24.74k | 3.33% $ 44.8m | |
| Independent Director | less than a year | US$19.91k | no data | |
| Independent Director | less than a year | US$19.24k | no data | |
| Independent Director | less than a year | no data | no data |
0.6yrs
Average Tenure
63.5yo
Average Age
Experienced Board: GYRE's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.